Copyright
©The Author(s) 2019.
World J Gastroenterol. Jan 28, 2019; 25(4): 457-468
Published online Jan 28, 2019. doi: 10.3748/wjg.v25.i4.457
Published online Jan 28, 2019. doi: 10.3748/wjg.v25.i4.457
Table 5 Comparison of therapeutic outcomes among patients receiving single- low-dose aspirin in the continuous low-dose aspirin group and the discontinuous low-dose aspirin group
| Continuous LDA (n = 56) | Discontinuous LDA (n = 39) | P value | |
| Pathological findings, n (%)1 | |||
| Differentiated | 55 (98.2) | 39 (100) | > 0.99 |
| Undifferentiated | 1 (1.8) | 0 (0) | |
| Depth of invasion, n (%) | |||
| Mucosa | 50 (89.3) | 33 (84.6) | 0.542 |
| Submucosa | 6 (10.7) | 6 (15.4) | |
| Specimen size, median (IQR), mm | 28 (22-37.3) | 31 (25-43.5) | 0.440 |
| Complete resection, n (%) | 53 (94.6) | 37 (94.9) | > 0.99 |
| Curative resection, n (%) | 52 (92.9) | 34 (87.2) | 0.480 |
| Postoperative bleeding, n (%) | 6 (10.7) | 4 (10.3) | > 0.99 |
- Citation: Harada H, Suehiro S, Murakami D, Nakahara R, Nagasaka T, Ujihara T, Sagami R, Katsuyama Y, Hayasaka K, Amano Y. Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy. World J Gastroenterol 2019; 25(4): 457-468
- URL: https://www.wjgnet.com/1007-9327/full/v25/i4/457.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i4.457